Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Quest Diagnostics



) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.8%. By the end of trading, Quest Diagnostics fell $0.66 (-1.1%) to $61.42 on average volume. Throughout the day, 1,895,267 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 1,899,700 shares. The stock ranged in price between $60.71-$62.13 after having opened the day at $61.86 as compared to the previous trading day's close of $62.08. Other companies within the Health Services industry that declined today were:

Bio-Reference Labs



), down 21.7%,

ERBA Diagnostics



), down 7.7%,

Organovo Holdings



), down 3.9% and

Baxano Surgical



), down 2.9%.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $9.1 billion and is part of the health care sector. The company has a P/E ratio of 12.0, below the S&P 500 P/E ratio of 17.7. Shares are up 7.0% year to date as of the close of trading on Tuesday. Currently there are 4 analysts that rate Quest Diagnostics a buy, 3 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates

Quest Diagnostics

as a


. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income, notable return on equity, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front,




), up 17.3%,




), up 14.8%,




), up 9.0% and

Unilife Corporation



), up 8.9% , were all gainers within the health services industry with

St Jude Medical



) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.